HeartBeam (BEAT) Cash from Operations (2020 - 2026)
HeartBeam's (BEAT) quarterly Cash from Operations came in at -$3.3 million in Q2 2026, up 2.99% year-over-year from -$3.2 million in Q2 2025, and up 7.42% quarter-over-quarter from -$3.6 million in Q1 2026.
Analysis
HeartBeam (BEAT) Cash from Operations (2020 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Cash from Operations for 7 consecutive years, with -$3.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 2.99% year-over-year to -$3.3 million in Q2 2026; TTM through Jun 2026 was -$13.0 million, a 15.36% increase from a year earlier, with the FY2025 full-year figure at -$14.0 million, up 3.34% from the prior year.
- Cash from Operations was -$3.3 million for Q2 2026 at HeartBeam, up from -$3.6 million in the prior quarter.
- Over five years, Cash from Operations peaked at -$1.9 million in Q2 2022 and troughed at -$4.5 million in Q1 2025.
- A 5-year average of -$3.2 million and a median of -$3.2 million in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 1409.03% in 2022 and jumped 30.01% in 2025, its largest moves.
- Over 5 years, Cash from Operations stood at -$3.0 million in 2022, then advanced by 3.28% to -$2.9 million in 2023, then tumbled by 45.28% to -$4.2 million in 2024, then jumped by 30.01% to -$2.9 million in 2025, then declined by 15.0% to -$3.3 million in 2026.
- The last three Cash from Operations figures came in at -$3.3 million (Q2 2026), -$3.6 million (Q1 2026), and -$2.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 454.63 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | -3.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.34 Mn |
| Mar 31, 2026 | -3.61 Mn |
| Dec 31, 2025 | -2.91 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Jun 30, 2025 | -3.45 Mn |
| Mar 31, 2025 | -4.48 Mn |
| Dec 31, 2024 | -4.15 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Dec 31, 2023 | -2.86 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | -4.02 Mn |
| Mar 31, 2023 | -3.11 Mn |
| Dec 31, 2022 | -2.96 Mn |
| Sep 30, 2022 | -2.73 Mn |
| Jun 30, 2022 | -1.93 Mn |
| Mar 31, 2022 | -2.34 Mn |
| Dec 31, 2021 | -2.44 Mn |
| Sep 30, 2021 | -365,000.00 |